Meta Analysis Confirms wearing hearing aids Reduces Dementia Risk by 67 Percent

Recent research on hearing aids and dementia risk has generated significant interest, but the specific 67% figure cited in headlines doesn't appear in...

Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.

Meta analysis sits at the center of this dementia and brain health question.

Recent research on hearing aids and dementia risk has generated significant interest, but the specific 67% figure cited in headlines doesn’t appear in peer-reviewed studies. The actual evidence is compelling but more nuanced. A groundbreaking 2025 study published in JAMA Neurology found that adults under 70 with untreated hearing loss who started using hearing aids experienced a 61% lower risk of developing dementia compared to those who didn’t address their hearing problems.

This finding has sparked renewed attention to hearing loss as a modifiable risk factor for cognitive decline, a discovery that could reshape how we approach dementia prevention. The broader research landscape reveals a consistent pattern: treating hearing loss with hearing aids appears to offer significant cognitive protection, though the magnitude of benefit varies depending on age, the severity of hearing loss, and how early treatment begins. This matters enormously because hearing loss affects approximately one in three adults over age 65, yet many people delay or avoid treatment for years.

Table of Contents

What Does the Research Actually Show About Hearing Aids and Dementia Risk?

The 2025 JAMA Neurology study stands as one of the most recent comprehensive examinations of this relationship. Researchers tracked adults with hearing loss and compared cognitive outcomes between those who adopted hearing aids and those who did not. The 61% risk reduction specifically applied to people under age 70, a critical detail often overlooked in simplified reporting. This wasn’t a small or marginal effect—it represented one of the strongest associations ever documented between a single intervention and dementia prevention.

Beyond this headline-making figure, the NIH-supported ACHIEVE study provided additional validation. Published in findings released in February 2026, this multi-year investigation found that hearing aid use reduced the rate of cognitive decline by approximately 50% in older adults at high risk of dementia over a three-year period. Johns Hopkins researchers separately documented a 32% lower prevalence of dementia in participants with moderate to severe hearing loss who used hearing aids. The variation in these percentages—61%, 50%, and 32%—reflects differences in study populations, definitions of dementia, and how “hearing aid use” was measured, but the direction is consistent: hearing aids matter.

What Does the Research Actually Show About Hearing Aids and Dementia Risk?

Why Does Hearing Loss Increase Dementia Risk in the First Place?

The mechanism linking untreated hearing loss to cognitive decline involves several interconnected processes. When hearing loss goes unaddressed, the brain must work harder to process degraded auditory signals, a phenomenon called “cognitive load.” Imagine trying to listen to a conversation in a noisy restaurant while also performing mental arithmetic—that’s roughly the constant state of someone with untreated hearing loss. Over years, this sustained cognitive strain may exhaust neural resources and contribute to the neurodegeneration associated with dementia. Additionally, hearing loss often leads to social withdrawal and isolation, factors independently linked to accelerated cognitive decline. People who struggle to hear conversations frequently begin avoiding social situations, which reduces cognitive stimulation and emotional connection—both protective factors for brain health.

A person who can’t comfortably participate in group dinners or phone calls with family members may spend increasing amounts of time alone, a risk factor that compounds the biological stress of untreated hearing loss. However, it’s important to acknowledge a limitation in the current research: most studies are observational rather than randomized controlled trials. This means we can document the association between hearing aid use and lower dementia risk, but we cannot definitively prove that hearing aids cause the risk reduction. Other unmeasured factors—such as health consciousness or access to healthcare—might explain some of the association. The 2024 Lancet Commission stated that “the evidence that treating hearing loss decreases the risk of dementia is now stronger,” but researchers continue working to understand causation versus correlation.

Dementia Risk Reduction with Hearing Aid Treatment Across StudiesJAMA 2025 (Under 70)61%ACHIEVE Study (3-Year)50%Johns Hopkins (Mod/Severe Loss)32%Source: JAMA Neurology 2025, NIH ACHIEVE Study 2026, Johns Hopkins Bloomberg School of Public Health

Does Age Matter for Hearing Aid Benefits?

Age emerged as a crucial variable in recent research. The strongest protective effect of hearing aids appeared in adults under 70 years old, where the 61% risk reduction was documented. For those aged 70 and older, the benefit of hearing aids on dementia risk was either reduced or absent in some analyses, though the cognitive and quality-of-life benefits remain significant. This age-related variation suggests that the window for preventing dementia through hearing aid intervention may have limits, making early detection and treatment of hearing loss increasingly important as we age.

This finding has real implications for how physicians and audiologists counsel patients. A 55-year-old with moderate hearing loss now has stronger evidence-based reasons to treat it promptly. Waiting until age 75 to address the same hearing loss may provide quality-of-life benefits but may miss the cognitive protection window. The 2024 Lancet Commission report emphasized that hearing aids are “particularly effective in people with hearing loss and additional risk factors for dementia,” suggesting that a person with both untreated hearing loss and, for example, hypertension or diabetes may benefit especially from prompt intervention.

Does Age Matter for Hearing Aid Benefits?

How Do You Actually Get Started With Hearing Aids?

The path to hearing aid adoption begins with testing and diagnosis. A simple hearing test—often available through primary care physicians, audiologists, or even community health programs—can identify whether hearing loss is present and how severe it is. Many insurance plans, including Medicare, cover hearing tests, though coverage for hearing aids themselves varies considerably. Some plans cover them fully, while others require out-of-pocket spending of $1,000 to $6,000 for a pair of advanced hearing aids. Once hearing loss is confirmed, working with an audiologist to select appropriate hearing aids is the next step. Modern hearing aids are vastly different from the visible, squealing devices of decades past.

Many people now use small, nearly invisible devices that connect to smartphones, adjust automatically to different environments, and filter out background noise. The fitting process typically involves multiple appointments to ensure the devices are calibrated to your specific hearing loss pattern and that you’re comfortable wearing them. This trial-and-adjustment period is normal and expected. A practical consideration often overlooked: hearing aids require ongoing maintenance, including battery changes or charging, periodic professional cleaning, and potential repair costs if damaged. Some people thrive with this routine; others find it cumbersome. Discussing realistic expectations with your audiologist—and being honest about your lifestyle and willingness to maintain the devices—leads to better long-term outcomes than rushing into purchase without careful consideration.

What Challenges Prevent People From Using Hearing Aids?

Despite clear evidence of benefit, roughly three-quarters of people with hearing loss in the United States have never tried hearing aids. Cost remains the leading barrier, particularly for those on fixed incomes or without insurance coverage. The stigma associated with hearing aids has diminished over time, especially as devices have become smaller and more discreet, but some people still experience embarrassment or denial about their hearing loss. Others try hearing aids briefly, become frustrated with the adjustment period, and abandon them before experiencing the benefits. Hearing aid adjustment takes time. In the first weeks, many people experience an unsettling sensation of amplification—familiar sounds now seem loud, or background noise becomes noticeable.

The brain needs weeks to relearn how to filter these signals, a process that feels uncomfortable to some users. A critical limitation in the research literature is that studies measuring dementia outcomes in “hearing aid users” typically only include people who persisted with the devices for months or years. People who tried hearing aids briefly but stopped are often excluded from analysis, meaning we don’t know whether intermittent or short-term use provides any cognitive benefit. Additionally, hearing aids work best when matched appropriately to a person’s specific hearing loss pattern. An inadequate fit or wrong device type can lead to poor results, patient dissatisfaction, and eventual abandonment. This underscores why working with a skilled audiologist matters more than simply purchasing devices online or through big-box retailers. An experienced professional can troubleshoot problems, adjust settings, and provide coaching through the adjustment period—services that directly support successful long-term use.

What Challenges Prevent People From Using Hearing Aids?

The ACHIEVE Study: Three Years of Evidence

The ACHIEVE study deserves closer examination because it provided one of the longest follow-up periods on hearing aids and cognition. Conducted across multiple research centers and involving hundreds of older adults with untreated hearing loss, this study randomly assigned participants to either receive hearing aids or to continue without treatment. Over three years, researchers administered standardized cognitive tests at regular intervals. The group that received hearing aids showed approximately 50% slower cognitive decline compared to the control group, a substantial difference that accumulated over the three-year period.

What made ACHIEVE particularly valuable was its randomized design, which provides stronger evidence for causation than observational studies. Participants in the hearing aid group received professional fitting and ongoing support, mirroring real-world clinical practice. The cognitive domains most protected included processing speed and attention—precisely the functions most vulnerable in early dementia. Importantly, this benefit appeared most clearly in people with more severe baseline hearing loss and those who consistently used their hearing aids, reinforcing that treatment quality and adherence matter.

What Does This Research Mean for the Future of Dementia Prevention?

As the Lancet Commission noted in its 2024 update, hearing loss now appears among the modifiable risk factors with the strongest evidence base for dementia prevention. Alongside other known protective factors like cognitive engagement, physical exercise, and management of cardiovascular risk, treating hearing loss represents a concrete step people can take. This shifts our conversation about dementia from a disease we can only manage after symptoms appear to one where earlier intervention might prevent or delay onset.

The research pipeline continues to examine unanswered questions. Ongoing studies are investigating whether even milder degrees of hearing loss carry cognitive risk, whether certain types of hearing loss are more strongly linked to dementia, and whether newer technologies like cochlear implants or bone-conduction devices offer additional benefits. As this evidence accumulates, the case for treating hearing loss as a routine part of preventive healthcare—comparable to managing blood pressure or cholesterol—only strengthens.

Conclusion

The evidence linking hearing loss treatment to dementia risk reduction is real and substantial, even though the specific 67% figure does not appear in peer-reviewed literature. The best current evidence shows a 61% risk reduction in adults under 70 who treat their hearing loss with hearing aids, along with approximately 50% slowing of cognitive decline documented in the ACHIEVE study. Given that hearing loss is common, readily diagnosable, and treatable, it represents one of the few modifiable dementia risk factors within our direct control.

If you or someone you care for has noticed signs of hearing loss—difficulty understanding conversations, need to turn up the television volume, or fatigue from straining to hear—a conversation with your primary care doctor or a visit to an audiologist represents a meaningful step toward cognitive protection. The research suggests that early intervention, particularly before age 70, may offer the greatest benefit. Waiting years to address hearing loss not only reduces quality of life today but may also reduce the protective window for dementia prevention. In the growing landscape of dementia prevention strategies, treating hearing loss stands as one of the most evidence-based and immediately actionable options available.


You Might Also Like

For more, see Alzheimer’s Association.